This Vanguard ETF Is Up 12% in 2026. Here's Whether Long-Term Investors Should Still Be Buying at These Levels.

The real risk here is not broad-market valuation in isolation; it’s concentration risk disguised as diversification. A market-cap-weighted index that leans so heavily on NVDA, MSFT, AAPL, and AMZN behaves more like a long-duration, mega-cap tech basket than a true S&P proxy, so any slowdown in AI capex or a de-rating in the top 10 can drag the whole complex even if the median stock is fine. That creates a second-order spillover into passive flows: once the largest names lose momentum, index buyers stop getting the mechanical support they’ve enjoyed from earnings revisions and factor crowding.

The catalyst path is mostly rates. Over 1-3 months, a backup in Treasury yields or a hawkish Fed repricing would pressure the index through multiple compression rather than earnings downgrades; the vulnerable leg is the portion of VOO owned for “safety,” not just growth. By contrast, if yields stabilize and AI spend remains intact, the index can stay expensive for longer than skeptics expect because passive flows and buybacks are a real bid.

Contrarian view: the consensus may be too eager to call the market “overvalued” without asking whether the earnings base is also structurally higher quality than prior cycles. The better question is whether broad-market exposure is the wrong instrument for a mega-cap-led tape. If AI spend broadens beyond NVDA/MSFT into customers like AAPL and AMZN, the index can keep compounding; if it narrows, the concentration premium likely unwinds quickly. Falsifier: 10Y yields holding below recent highs and forward EPS revisions staying positive would keep this thesis from working.